Published in FEMS Yeast Res on June 01, 2006
Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis (2009) 2.37
Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Appl Environ Microbiol (2006) 2.12
Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS One (2009) 1.56
Cryptococcus gattii infections. Clin Microbiol Rev (2014) 1.55
Evolution of eukaryotic microbial pathogens via covert sexual reproduction. Cell Host Microbe (2010) 1.50
Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal. MBio (2014) 1.45
Furthering the Continental Drift Speciation Hypothesis in the Pathogenic Cryptococcus Species Complexes. mSphere (2017) 1.39
Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea. FEMS Yeast Res (2010) 1.32
Cryptococcus gattii: An Emerging Cause of Fungal Disease in North America. Interdiscip Perspect Infect Dis (2009) 1.31
Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect (2011) 1.31
Heteroresistance of Cryptococcus gattii to fluconazole. Antimicrob Agents Chemother (2010) 1.26
Global Molecular Epidemiology of Cryptococcus neoformans and Cryptococcus gattii: An Atlas of the Molecular Types. Scientifica (Cairo) (2013) 1.12
Microsatellite typing of clinical and environmental Cryptococcus neoformans var. grubii isolates from Cuba shows multiple genetic lineages. PLoS One (2010) 1.10
Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand. PLoS Negl Trop Dis (2013) 1.09
Cryptococcus gattii outbreak expands into the Northwestern United States with fatal consequences. F1000 Biol Rep (2009) 1.08
Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010. PLoS One (2013) 1.04
Cryptococcus gattii virulence composite: candidate genes revealed by microarray analysis of high and less virulent Vancouver island outbreak strains. PLoS One (2011) 1.02
Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment. Eur J Clin Microbiol Infect Dis (2013) 0.97
De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans. PLoS Pathog (2012) 0.94
Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii. Mycopathologia (2008) 0.88
Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattii. PLoS One (2014) 0.87
Cryptococcus spp isolated from dust microhabitat in Brazilian libraries. J Occup Med Toxicol (2012) 0.80
Cryptococcosis of lumbar vertebra in a patient with rheumatoid arthritis and scleroderma: case report and literature review. BMC Infect Dis (2013) 0.79
Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011. PLoS Negl Trop Dis (2014) 0.77
Distribution and association between environmental and clinical isolates of Cryptococcus neoformans in Bogotá-Colombia, 2012-2015. Mem Inst Oswaldo Cruz (2016) 0.75
Magnesium Ion Acts as a Signal for Capsule Induction in Cryptococcus neoformans. Front Microbiol (2016) 0.75
The amsterdam declaration on fungal nomenclature. IMA Fungus (2011) 5.86
Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis (2003) 3.34
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis (2013) 1.76
Survey of simple sequence repeats in completed fungal genomes. Mol Biol Evol (2004) 1.73
Changes to airborne pollen counts across Europe. PLoS One (2012) 1.62
Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One (2011) 1.57
Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS One (2009) 1.56
A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays. Med Mycol (2002) 1.56
Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii. Eukaryot Cell (2005) 1.48
Feline cryptococcosis: impact of current research on clinical management. J Feline Med Surg (2011) 1.43
[Case reports of drug-induced liver injury in a reference hospital of Zulia state, Venezuela]. Invest Clin (2015) 1.39
The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex. FEMS Yeast Res (2004) 1.38
Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea. FEMS Yeast Res (2010) 1.32
Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase. J Clin Microbiol (2008) 1.30
Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics (2009) 1.25
Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. Mem Inst Oswaldo Cruz (2008) 1.21
The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii. Infect Immun (2009) 1.21
Re-examining the phylogeny of clinically relevant Candida species and allied genera based on multigene analyses. FEMS Yeast Res (2008) 1.17
Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLoS One (2013) 1.15
Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: a countrywide surveillance. Int J Infect Dis (2007) 1.13
Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex. Med Mycol (2011) 1.13
Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand. PLoS Negl Trop Dis (2013) 1.09
Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis (2012) 1.09
Clonality and α-a recombination in the Australian Cryptococcus gattii VGII population--an emerging outbreak in Australia. PLoS One (2011) 1.08
MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex. PLoS One (2012) 1.07
Tracking methicillin-resistant Staphylococcus aureus clones in Colombian hospitals over 7 years (1996-2003): emergence of a new dominant clone. Int J Antimicrob Agents (2005) 1.06
Nosocomial Pneumocystis jirovecii pneumonia: lessons from a cluster in kidney transplant recipients. Transplantation (2011) 1.06
Genotyping of Scedosporium species: a review of molecular approaches. Med Mycol (2008) 1.05
Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. FEMS Yeast Res (2003) 1.04
Cryptococcus gattii virulence composite: candidate genes revealed by microarray analysis of high and less virulent Vancouver island outbreak strains. PLoS One (2011) 1.02
Primary endemic Cryptococcosis gattii by molecular type VGII in the state of Pará, Brazil. Mem Inst Oswaldo Cruz (2008) 1.01
Multilocus microsatellite typing for Cryptococcus neoformans var. grubii. Med Mycol (2008) 1.01
Histoplasmosis: results of the Colombian national survey, 1992-2008. Biomedica (2012) 1.00
[Characterization of invasive isolates of S. pneumoniae, H. influenzae, and N. meningitidis in Latin America and the Caribbean: SIREVA II, 2000-2005]. Rev Panam Salud Publica (2008) 0.99
SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans. Mol Microbiol (2011) 0.99
Identification of human papillomavirus type 156, the prototype of a new human gammapapillomavirus species, by a generic and highly sensitive PCR strategy for long DNA fragments. J Gen Virol (2012) 0.99
Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII. Mycopathologia (2011) 0.99
Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis. Med Mycol (2010) 0.98
Influence of climatic conditions on the isolation of members of the Cryptococcus neoformans species complex from trees in Colombia from 1992-2004. FEMS Yeast Res (2006) 0.97
Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum. Emerg Infect Dis (2008) 0.97
Isolation and characterisation of the phospholipase B gene of Cryptococcus neoformans var. gattii. FEMS Yeast Res (2002) 0.96
Association between fertility and molecular sub-type of global isolates of Cryptococcus gattii molecular type VGII. Med Mycol (2008) 0.96
Geographically structured populations of Cryptococcus neoformans Variety grubii in Asia correlate with HIV status and show a clonal population structure. PLoS One (2013) 0.96
Molecular subtyping of Salmonella enterica serovar Typhi isolates from Colombia and Argentina. Foodborne Pathog Dis (2006) 0.96
Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia. Med Mycol (2013) 0.96
Evolution of an international external quality assurance model to support laboratory investigation of Streptococcus pneumoniae, developed for the SIREVA project in Latin America, from 1993 to 2005. J Clin Microbiol (2007) 0.95
Hyperbranched rolling circle amplification as a rapid and sensitive method for species identification within the Cryptococcus species complex. Electrophoresis (2008) 0.95
Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes. J Clin Microbiol (2009) 0.95
Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS One (2011) 0.94
Detection and serotyping of Streptococcus pneumoniae from nasopharyngeal samples by PCR-based multiplex assay. J Clin Microbiol (2005) 0.94
Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors? Med Mycol (2010) 0.94
PCR-restriction fragment length polymorphism analysis of the phospholipase B (PLB1) gene for subtyping of Cryptococcus neoformans isolates. Appl Environ Microbiol (2003) 0.93
Development and validation of a multiplex PCR for detection of Scedosporium spp. in respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol (2011) 0.89
[Environmental distribution of Cryptococcus neoformans in the department of Cundinamarca-Colombia]. Rev Iberoam Micol (2005) 0.88
[Streptococcus agalactiae meningitis in an immunocompetent male]. Enferm Infecc Microbiol Clin (2011) 0.87
[Results of nine years of the clinical and epidemiological survey on cryptococcosis in Colombia, 1997-2005]. Biomedica (2007) 0.87
Comparison of different DNA-based methods for molecular typing of Histoplasma capsulatum. Appl Environ Microbiol (2010) 0.87
Fatal mycotic aneurysms due to Scedosporium and Pseudallescheria infection. J Clin Microbiol (2011) 0.87
Identification and structural characterization of serobactins, a suite of lipopeptide siderophores produced by the grass endophyte Herbaspirillum seropedicae. Environ Microbiol (2013) 0.87
Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries. Vaccine (2011) 0.85
Dissemination of Streptococcus pneumoniae clone Colombia(5)-19 in Latin America. J Clin Microbiol (2002) 0.84
Development of polymorphic microsatellite markers for Cryptococcus neoformans. Mol Ecol Resour (2008) 0.84
Pathogenesis of pulmonary Cryptococcus gattii infection: a rat model. Mycopathologia (2010) 0.84
Clinical features and epidemiology of cryptococcosis in cats and dogs in California: 93 cases (1988-2010). J Am Vet Med Assoc (2011) 0.83
Scedosporium aurantiacum is as virulent as S. prolificans, and shows strain-specific virulence differences, in a mouse model. Med Mycol (2010) 0.82
Fungal infections and treatment in cystic fibrosis. Curr Opin Pulm Med (2013) 0.82
[Isolation of Cryptococcus gattii serotype B from detritus of Eucalyptus trees in Colombia]. Biomedica (2005) 0.82
Circulation of Streptococcus pneumoniae clone Colombia 5 ST289 in nine Latin American countries. Rev Panam Salud Publica (2009) 0.82
Cryptococcosis in Colombia: results of the national surveillance program for the years 2006-2010. Biomedica (2012) 0.82
Molecular epidemiology linking multihospital clusters of opportunistic Pneumocystis jirovecii pneumonia. Clin Infect Dis (2013) 0.81
New generic primer system targeting mucosal/genital and cutaneous human papillomaviruses leads to the characterization of HPV 115, a novel Beta-papillomavirus species 3. Virology (2009) 0.81
Taxonomy of medically important fungi in the molecular era. Lancet Infect Dis (2013) 0.81
Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice. Biomedica (2005) 0.81
Multilocus sequence typing (MLST) and M13 PCR fingerprinting revealed heterogeneity amongst Cryptococcus species obtained from Italian veterinary isolates. FEMS Yeast Res (2014) 0.81
Molecular epidemiology of invasive aspergillosis: lessons learned from an outbreak investigation in an Australian hematology unit. Infect Control Hosp Epidemiol (2009) 0.80
Identification of genomic differences between Cryptococcus neoformans and Cryptococcus gattii by Representational Difference Analysis (RDA). Med Mycol (2009) 0.79
[Phenotype characterization of environmental Cryptococcus neoformans isolates]. Biomedica (2003) 0.78
In vitro mating of Colombian isolates of the Cryptococcus neoformans species complex. Biomedica (2007) 0.78
[Noninvasive diagnosis of esophageal varices in cirrhotic patients]. Acta Gastroenterol Latinoam (2014) 0.78
[Experimental inoculation of Terminalia catappa seedlings with an environmental isolate of Cryptococcus neoformans var. gattii serotype C ]. Biomedica (2002) 0.78
[Increase in erythromycin-resistant Streptococcus pneumoniae in Colombia, 1994-2008]. Biomedica (2011) 0.77
Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus. Cytotherapy (2012) 0.77
[Streptococcus pneumoniae: serotype evolution and patterns of antimicrobial susceptibility in invasive isolates from 11 years surveillance (1994 -2004) in Colombia]. Biomedica (2006) 0.77
[Characterization by pulsed-field gel electrophoresis of Salmonella typhimurium isolates recovered in the acute diarrheal disease surveillance program in Colombia, 1997-2004]. Biomedica (2006) 0.77
MLST and Whole-Genome-Based Population Analysis of Cryptococcus gattii VGIII Links Clinical, Veterinary and Environmental Strains, and Reveals Divergent Serotype Specific Sub-populations and Distant Ancestors. PLoS Negl Trop Dis (2016) 0.77
[Acute diarrhea outbreak caused by Shigella flexneri at a school in Madrid, Cundinamarca: phenotypic and genotypic characterization of the isolates]. Biomedica (2002) 0.77
[Resistance to non-beta-lactam antibiotics in the clinical isolates of Streptococcus pneumoniae of children in Latin America. SIREVA II, 2000-2005]. Rev Panam Salud Publica (2009) 0.77
[In vitro determination of virulence factors activity associated with several Cryptococcus neoformans clinical isolates]. Rev Iberoam Micol (2008) 0.77
[Regional laboratory network for surveillance of invasive fungal infections and antifungal susceptibility in Latin America]. Rev Panam Salud Publica (2008) 0.76
Isolation of Cryptococcus neoformans var. neoformans serotype D from Eucalypts in South Brazil. Med Mycol (2006) 0.76
[Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci]. Biomedica (2008) 0.76
[Identification of Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis by polymerase chain reaction]. Biomedica (2007) 0.76
[Molecular surveillance of invasive penicillin-resistant Streptococcus pneumoniae Colombian isolates recovered from children less than 5 years of age]. Biomedica (2004) 0.76
[Surveillance of Haemophilus influenzae serotypes and antimicrobial resistance in Colombia, 1994-2002]. Biomedica (2003) 0.76
Distribution and association between environmental and clinical isolates of Cryptococcus neoformans in Bogotá-Colombia, 2012-2015. Mem Inst Oswaldo Cruz (2016) 0.75
Umbelopsis dimorpha sp. nov., a link between U. vinacea and U. versiformis. Mycol Res (2004) 0.75
Antioxidant activity, cellular bioavailability, and iron and calcium management of neuroprotective and nonneuroprotective flavones. Neurotox Res (2014) 0.75